FR2018062B1 - - Google Patents

Info

Publication number
FR2018062B1
FR2018062B1 FR6931141A FR6931141A FR2018062B1 FR 2018062 B1 FR2018062 B1 FR 2018062B1 FR 6931141 A FR6931141 A FR 6931141A FR 6931141 A FR6931141 A FR 6931141A FR 2018062 B1 FR2018062 B1 FR 2018062B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR6931141A
Other languages
French (fr)
Other versions
FR2018062A1 (cg-RX-API-DMAC7.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of FR2018062A1 publication Critical patent/FR2018062A1/fr
Application granted granted Critical
Publication of FR2018062B1 publication Critical patent/FR2018062B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/18—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR6931141A 1968-09-13 1969-09-12 Expired FR2018062B1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4362868 1968-09-13

Publications (2)

Publication Number Publication Date
FR2018062A1 FR2018062A1 (cg-RX-API-DMAC7.html) 1970-05-29
FR2018062B1 true FR2018062B1 (cg-RX-API-DMAC7.html) 1974-01-11

Family

ID=10429626

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6931141A Expired FR2018062B1 (cg-RX-API-DMAC7.html) 1968-09-13 1969-09-12

Country Status (5)

Country Link
BE (1) BE738831A (cg-RX-API-DMAC7.html)
DE (1) DE1946638A1 (cg-RX-API-DMAC7.html)
FR (1) FR2018062B1 (cg-RX-API-DMAC7.html)
GB (1) GB1227978A (cg-RX-API-DMAC7.html)
NL (1) NL6913673A (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58150576A (ja) * 1982-03-03 1983-09-07 Sumitomo Chem Co Ltd 新規な1,2,4−オキサジアゾ−ル誘導体
US4562186A (en) * 1985-01-22 1985-12-31 Hoechst-Roussel Pharmaceuticals Inc. (1,2,4-Oxadiazol-3-yl)arylmethanones, compositions and pharmaceutical use
EP1047425A4 (en) * 1997-12-17 2009-04-22 Merck & Co Inc INTEGRIN RECEPTOR ANTAGONISTS
US12624011B2 (en) * 2020-03-17 2026-05-12 Sumitomo Pharma Co., Ltd. Oxadiazole derivative

Also Published As

Publication number Publication date
BE738831A (cg-RX-API-DMAC7.html) 1970-03-12
NL6913673A (cg-RX-API-DMAC7.html) 1970-03-17
GB1227978A (cg-RX-API-DMAC7.html) 1971-04-15
FR2018062A1 (cg-RX-API-DMAC7.html) 1970-05-29
DE1946638A1 (de) 1970-09-03

Similar Documents

Publication Publication Date Title
AU1946070A (cg-RX-API-DMAC7.html)
AU428130B2 (cg-RX-API-DMAC7.html)
AU5184069A (cg-RX-API-DMAC7.html)
AU6168869A (cg-RX-API-DMAC7.html)
AU6171569A (cg-RX-API-DMAC7.html)
FR2018062A1 (cg-RX-API-DMAC7.html)
AU2952567A (cg-RX-API-DMAC7.html)
AU2581067A (cg-RX-API-DMAC7.html)
AU4811568A (cg-RX-API-DMAC7.html)
AU421558B1 (cg-RX-API-DMAC7.html)
AU3789668A (cg-RX-API-DMAC7.html)
AR203075Q (cg-RX-API-DMAC7.html)
AU4744468A (cg-RX-API-DMAC7.html)
AU3224368A (cg-RX-API-DMAC7.html)
AU2580267A (cg-RX-API-DMAC7.html)
BE642636A (cg-RX-API-DMAC7.html)
BE726619A (cg-RX-API-DMAC7.html)
BE709484A (cg-RX-API-DMAC7.html)
AU2496167A (cg-RX-API-DMAC7.html)
BE708933A (cg-RX-API-DMAC7.html)
BE709095A (cg-RX-API-DMAC7.html)
BE581157A (cg-RX-API-DMAC7.html)
BE728555A (cg-RX-API-DMAC7.html)
AU3083868A (cg-RX-API-DMAC7.html)
BE727332A (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
ST Notification of lapse